ALEJANDRO
OLIVARES HERNÁNDEZ
Researcher from 2019
LUIS
POSADO DOMÍNGUEZ
Investigador Predoctoral
Publications by the researcher in collaboration with LUIS POSADO DOMÍNGUEZ (13)
2025
-
A comprehensive review of sex differences in the clinical outcomes to immunotherapy on solid tumors
Clinical and Translational Oncology
-
Corrigendum to “Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review” [Clin. Translat. Radiat. Oncol. 52 (2025) 100930](S2405630825000205)(10.1016/j.ctro.2025.100930)
Clinical and Translational Radiation Oncology
-
Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review
Precision Cancer Medicine, Vol. 7, pp. 1-13
-
Evaluation of the effect of metformin as a radiosensitiser in solid tumours: A systematic review
Clinical and Translational Radiation Oncology, Vol. 52
-
Neoadjuvant chemoimmunotherapy or chemoradiotherapy in stage III non-small cell lung cancer: crossing the Rubicon?
Chinese Clinical Oncology, Vol. 14, Núm. 5
-
Prognostic impact of negative TTF-1 biomarker in metastatic lung adenocarcinoma treated with chemo-immunotherapy: a retrospective cohort study
Translational Lung Cancer Research, Vol. 14, Núm. 7, pp. 2494-2508
2024
-
Cancer-Associated Thrombotic Microangiopathy: Literature Review and Report of Five Cases
Life, Vol. 14, Núm. 7
-
Current and future perspectives in clinical practice in KRAS-mutated non-small cell lung cancer: a literature review
Precision Cancer Medicine, pp. 1-13
-
No one writes to the colonel: (Pag.-e 102173)
Semergen: revista española de medicina de familia, Núm. 4, pp. 10-10
-
Paraneoplastic leukocytosis secondary to carcinosarcoma: a report of two cases and literature review
Chinese Clinical Oncology, Vol. 13, Núm. 3
-
Response to platinum-based therapies in second-line after immunotherapy in advanced or metastatic non-small-cell lung cancer PD-L1 ≥50%
Translational Lung Cancer Research, Vol. 13, Núm. 10, pp. 2649-2659
2023
-
Cardiotoxicity Secondary to Immune Checkpoint Inhibitors in the Elderly: Safety in Real-World Data
Cancers, Vol. 15, Núm. 17
-
Efficacy and safety of PARP inhibitor in non-small cell lung cancer: a systematic review with meta-analysis
Chinese Clinical Oncology, Vol. 12, Núm. 6